Beiyuan Hu

Shanghai Jiao Tong University — China

Medicine · Health Sciences

14h-index1.9kcitations29works12.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(7), Pancreatic and Hepatic Oncology Research(5), Cancer Mechanisms and Therapy(5), Epigenetics and DNA Methylation(4), Cancer Cells and Metastasis(3)

Publications29 total

Efficacy of multimodal thermal therapy combined with immune checkpoint inhibitors and chemotherapy in unresectable pancreatic cancer with liver metastases.
Journal of Clinical Oncology·2025· 1 cited
Microneedle Patch-Aided Intratumor Co-Delivery of FOLFIRINOX, Surufatinib and αPD-1 for Synergistic Efficacy of Combined Chemo- and Immuno-Therapy of PDAC
SSRN Electronic Journal·2025Open Access
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma
Experimental Hematology and Oncology·2024· 24 citedOpen Access
Early Diagnosis and Prognosis Prediction of Pancreatic Cancer Using Engineered Hybrid Core‐Shells in Laser Desorption/Ionization Mass Spectrometry
Advanced Materials·2024· 25 citedOpen Access
Single-cell mapping reveals several immune subsets associated with liver metastasis of pancreatic ductal adenocarcinoma
Med·2023· 12 citedOpen Access
Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression
Cell Reports·2023· 50 citedOpen Access
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma
Research Square (Research Square)·2023· 1 citedOpen Access
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
2023Open Access
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
2023Open Access
Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
2023Open Access
Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
2023Open Access
Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips
iScience·2022· 7 citedOpen Access
Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Cancer Research·2022· 157 citedOpen Access
Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations
Genes·2022· 4 citedOpen Access
IL-6 Promotes Hepatocellular Carcinoma Invasion by Releasing Exosomal miR-133a-3p
Gastroenterology Research and Practice·2022· 5 citedOpen Access
Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma
Annals of Translational Medicine·2022· 73 citedOpen Access
A Prognostic Nomogram for Hepatocellular Carcinoma Based on Wound Healing and Immune Checkpoint Genes
Journal of Clinical and Translational Hepatology·2022· 4 citedOpen Access
Regulation of Cellular Metabolism by Protein Crotonylation Coordinates Pancreatic Cancer Progression
SSRN Electronic Journal·2022Open Access
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
Signal Transduction and Targeted Therapy·2021· 338 citedOpen Access
Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma
BMC Surgery·2021· 2 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Qiongzhu Dong(20), Lun–Xiu Qin(18), Yan Zheng(13), Wei Qin(11), Xiaotian Shen(11), Le Zhu(10), Tiantian Zou(10), Haoting Sun(8), Yan Fu(8), Tian‐En Li(8), Shun Wang(7), Xudong Ren(7), Shun Wang(6), Ze Zhang(6), Chaoqun Wang(5), Yinghan Su(5), Jianhua Li(5), Yang Chen(5), Chao-Qun Wang(5), Zhengxin Wang(5)